This study describes CholesteroNitrone <b>2</b> as an antioxidant and neuroprotective agent against ischemic injury. Neuroprotection was assessed using in vitro and in vivo experimental ischemia models. The compound significantly increased cell viability, induced neuroprotection following ischemic reperfusion, and decreased neurological deficit scores in treated animals, supporting the next preclinical studies as a potential agent for the treatment of stroke
Background—The atheroma-retarding properties of b-hydroxy-b-methylglutaryl coenzyme A reductase (HMG...
Stroke is a leading cause of death and disability and treatment options are limited. A promising app...
A new era for neuroprotective strategies is emerging in ischemia/reperfusion. This has forced to rev...
This study describes CholesteroNitrone <b>2</b> as an antioxidant and neuroprotective agent against ...
This study describes CholesteroNitrone 2 as an antioxidant and neuroprotective agent against ischemi...
Nitrones have a well-recognized capacity as spin-traps and are considered powerful free radical scav...
Purpose: To investigate the neuroprotective potential of apocynin nitrone (AN-1), a nitrone analogue...
Neuroprotection seeks to restrict injury to the brain parenchyma following an ischaemic insult by pr...
Neuroprotection seeks to restrict injury to the brain parenchyma following an ischaemic insult by pr...
Stroke is the leading cause of adult disability and remains the third most common cause of death in ...
With the availability and ease of small molecule production and design continuing to improve, robust...
<div><p>With the availability and ease of small molecule production and design continuing to improve...
Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions Ischemi...
We describe herein the synthesis and neuroprotective capacity of an array of 31 compounds comprising...
We describe herein the synthesis and neuroprotective capacity of an array of 31 compounds comprising...
Background—The atheroma-retarding properties of b-hydroxy-b-methylglutaryl coenzyme A reductase (HMG...
Stroke is a leading cause of death and disability and treatment options are limited. A promising app...
A new era for neuroprotective strategies is emerging in ischemia/reperfusion. This has forced to rev...
This study describes CholesteroNitrone <b>2</b> as an antioxidant and neuroprotective agent against ...
This study describes CholesteroNitrone 2 as an antioxidant and neuroprotective agent against ischemi...
Nitrones have a well-recognized capacity as spin-traps and are considered powerful free radical scav...
Purpose: To investigate the neuroprotective potential of apocynin nitrone (AN-1), a nitrone analogue...
Neuroprotection seeks to restrict injury to the brain parenchyma following an ischaemic insult by pr...
Neuroprotection seeks to restrict injury to the brain parenchyma following an ischaemic insult by pr...
Stroke is the leading cause of adult disability and remains the third most common cause of death in ...
With the availability and ease of small molecule production and design continuing to improve, robust...
<div><p>With the availability and ease of small molecule production and design continuing to improve...
Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions Ischemi...
We describe herein the synthesis and neuroprotective capacity of an array of 31 compounds comprising...
We describe herein the synthesis and neuroprotective capacity of an array of 31 compounds comprising...
Background—The atheroma-retarding properties of b-hydroxy-b-methylglutaryl coenzyme A reductase (HMG...
Stroke is a leading cause of death and disability and treatment options are limited. A promising app...
A new era for neuroprotective strategies is emerging in ischemia/reperfusion. This has forced to rev...